Cargando…
Rising serum values of beta-subunit human chorionic gonadotrophin (hCG) in patients with progressive vulvar carcinomas.
Elevated serum levels of the beta-subunit of human chorionic gonadotrophin (hCG) were measured in 50% of patients with locoregional recurrences or progressive vulvar carcinoma (n = 14). At diagnosis of vulvar cancer, however, the incidence of elevated serum levels was low (5%) in 104 patients. The r...
Autores principales: | de Bruijn, H. W., ten Hoor, K. A., Krans, M., van der Zee, A. G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2222794/ https://www.ncbi.nlm.nih.gov/pubmed/9099973 |
Ejemplares similares
-
(125)I-labelled human chorionic gonadotrophin (hCG) as an elimination marker in the evaluation of hCG decline during chemotherapy in patients with testicular cancer
por: Christensen, T B, et al.
Publicado: (1999) -
The expression of Beta Human Chorionic Gonadotrophin (β-HCG) in human urothelial carcinoma
por: Venyo, Anthony Kodzo-Grey, et al.
Publicado: (2010) -
Association between altered placental human chorionic gonadotrophin (hCG) production and the occurrence of cryptorchidism: a retrospective study
por: Chedane, Carole, et al.
Publicado: (2014) -
The Impact of Endometrial Thickness on the Day of Human Chorionic Gonadotrophin (hCG) Administration on Ongoing Pregnancy Rate in Patients with Different Ovarian Response
por: Bu, Zhiqin, et al.
Publicado: (2015) -
SDS-PAGE Electrophoretic Property of Human Chorionic Gonadotropin (hCG) and its β-subunit
por: Gam, Lay-Harn, et al.
Publicado: (2005)